WEBSITECHANGES

Website Changes

---

07/04/2023

Copay Assistance Program is now open!

---

07/01/2023

Share Your Experiences With Glioblastoma Multiforme (GBM)

---

07/01/2023

Plus Therapeutics Releases Early-Cut Data From Cancer Studies For Brain Cancer Settings

---

06/30/2023

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

---

06/29/2023

Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers

---

06/22/2023

1000 Patients Treated With GammaTile Therapy

---

06/21/2023

xCures and DDRFA partner to make an impact on patient-driven DIPG & DMG research

---

06/21/2023

Quick survey on your brain tumor knowledge!

---

06/20/2023

AANS/CNS Section on Tumors and the World Federation of Neurosurgical Societies are hosting a GBM symposium

---

06/20/2023

Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial

---

06/18/2023

Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions

---

06/18/2023

Senators introduce legislation to lower cost of cancer treatments

---

06/17/2023

GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis

---

06/12/2023

Stanford Scientists Identify Genes Linked to Familial Brain Cancer

---

06/12/2023

Dr Henry Friedman podcast

---

06/08/2023

Senators Braun, Gillibrand, colleagues introduce bipartisan Promising Pathway Act to help patients with ALS and other life-threatening diseases get treatments

---

06/08/2023

Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial

---

06/05/2023

Brain Tumor Biotech Summit 2023 - this Friday June 9, 2023

---

06/05/2023

Use of proton pump inhibitors (PPI) in glioblastoma (GBM) and relationship to overall survival in a national real-world evidence (RWE) database.

---

06/04/2023

Vorasidenib first ‘game changer’ in 20 years for patients with IDH-mutant grade 2 glioma

---

06/04/2023

DCVax®-L: Mechanism of Action, Immunological Effects, and Clinical Trial External Controls Methodology

---

05/30/2023

GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy

---

05/30/2023

Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study

---

05/22/2023

Updated NCCN Guidelines for Brain Tumors

---

05/22/2023

New legislation proposed to expedite FDA approval process for life-threatening disease treatments

---